Clinical Research (Field)

Clinical Research (Field) Companies (16)

Clinical Research (Field) News

All news
show more news

Clinical Research (Field) Products (35)

  • Product Orphan Drug Development

    Accelerating orphan drug development from candidate selection to commercial manufacture and supply.

    - Integrated capabilities and expertise- Pre-formulation and API characterisation
    - Formulation and process development
    - First-in-human clinical testing and acceleration into POC trials
    - Be...
    Orphan Drug Development

  • Product GCP Services(Good Clinical Practices)

    We offer various GCP services which can help the clients across globe, ranging from audits to monitoring services. We provide comprehensive GCP Quality Compliance services to the pharmaceutical industry. Our GCP consulting services are characterized by:

    1) Knowledge: Various regulatory requi...
    GCP Services(Good Clinical Practices)

  • Product Phase I-IV Clinical Trials

    Lambda provides clinical development services spanning Phase I through Phase IV, combining early-phase clinical research with extensive late-phase trial capabilities. 

    Early-phase expertise includes first-in-human, single and multiple ascending dose, biosimilar, drug-drug interaction, food-effe...
    Phase I-IV Clinical Trials

  • Product Medea

    Medea™ automates the most time-consuming phases of Clinical Evaluation Report production — helping Medical Device compliance teams and CROs meet EU MDR 2017/745 requirements faster, more accurately, and with permanent audit readiness.

    The Problem Medea™ SolvesUnder EU MDR 2017/745, every medical dev...
    Medea

  • Product Ethynyl Estradiol 3-beta-D-Glucuronide

    CAT. No :E050038CAS. No :60134-76-1
    Mol. F :C26H32O8
    Mol. Wt :472.53 g/mol
    Synonyms :17alpha-Ethynylestradiol 3-glucuronide
    Chemical Name :(17alpha)-17-Hydroxy-19-norpregna-1,3,5(10)-trien-20-yn-3-yl beta-D-glucopyranosiduronic acid 
    Stock Status :Instock
    Ethynyl Estradiol 3-beta-D-Glucuronide

  • Product Early Phase Clinical Study Expertise

    State-of-the-art phase I/ll unit supporting complex clinical trials First in Human ( FIH) to Proof of Concept ( PoC) Clinical pharmacology studies through all phases In-house safety lab and bioanalytical services Special patient populations (with a focus on respiratory) Data management, regulatory sup...
    Early Phase Clinical Study Expertise

  • Product Nitrosamine Analysis

    In response to nitrosamines present in pharmaceutical products, the European Medical Agency (EMA) and the US Food and Drug Administration (US FDA) have published requirements and limits related to nitrosamine contaminants. Therefore Brightlabs has developed and validated multiple methods to determine low l...
    Nitrosamine Analysis

  • Product SAME UP

    FOOD SUPPLEMENT WITH S-ADENOSYLMETHIONINE (SAMe) AND LACTIC FERMENTS
    Helps to manage mood swings

    PRODUCT

    Our nutraceutical product helps border-line patients with predepression syndrome.
    The start of a depressive disorder is not the same as a passing blue mood. Without treatm...
    SAME UP

  • Product Clinical trial material (CTM) manufacturing and release

    We offer capabilities for manufacturing of small and large scale clinical trial material (CTM) as well as characterization and release from phase 1 to phase 3.
    Clinical trial material (CTM) manufacturing and release

  • Product Capebio Supermix Platform

    One-Step varieties for fast detection of infectious pathogens. 
    Capebio Supermix Platform

  • Product PK/PD Studies

    Lambda provides comprehensive PK/PD study capabilities across early clinical development, supported by extensive clinical research, bioanalytical, pharmacokinetic and pharmacodynamic expertise. Experience includes first-in-human, single and multiple ascending dose, food-effect, drug-drug interaction, compa...
    PK/PD Studies

  • Product Laboratory Services: Bioanalytical, Biosimilars and Clinical Lab

    Lambda provides integrated laboratory services spanning regulated bioanalysis, biosimilar development and central clinical laboratory testing. Capabilities support clinical development through bioanalytical testing, immunogenicity assessment, biomarker analysis and clinical laboratory testing. The central...
    Laboratory Services: Bioanalytical, Biosimilars and Clinical Lab

  • Product Medical Imaging Analysis

    Lambda provides centralized medical imaging services for clinical trials, with capabilities covering image management, centralized image review and reporting, query management and endpoint evaluation. A panel of experienced radiologists supports image assessment across multiple modalities, including OCT, F...
    Medical Imaging Analysis

  • Product Pharmacovigilance

    Lambda provides end-to-end drug safety and pharmacovigilance support from clinical trials through post-marketing activities. Services include ICSR case processing and electronic submissions, aggregate reports, risk management plans, literature monitoring, signal detection and management, xEVMPD compliance,...
    Pharmacovigilance

  • Product Biostatistics and Data Management

    Lambda provides biostatistics and clinical data management capabilities as part of its integrated clinical development model. The function supports clinical programs alongside clinical operations, medical writing, pharmacovigilance, medical imaging, laboratory services, and regulatory affairs. Data managem...
    Biostatistics and Data Management

  • Product Mycophenolic Acid Beta-D-Glucuronide

    CAT. No :M070031CAS. No :31528-44-6
    Mol. F :C23H28O12
    Mol. Wt :496.46 g/mol
    Synonyms :5-[(2E)-5-Carboxy-3-methyl-2-penten-1-yl]-1,3-dihydro-6-methoxy-7-methyl-3-oxo-4-isobenzofuranyl beta-D-Glucopyranosiduronic Acid;Mycophenolic Acid Glucosiduronate;Mycophenolic Acid Glucuronide
    Chemical Name :...
    Mycophenolic Acid Beta-D-Glucuronide

  • Product Rac Ruxolitinib D9

    CAT. No :R650005CAS. No :2469553-67-9
    Mol. F :C17H9D9N6
    Mol. Wt :315.42 g/molSynonyms :beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile-d9
    Chemical Name :3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-(cyclopentyl-d9)propanenitrile
    Stock Status :Instock
    Rac Ruxolitinib D9

  • Product Sitagliptin D4 Hydrochloride

    CAT. No :S060025CAS. No :NA
    Mol. F :C16H11F6N5OD4.HCl
    Mol. Wt :447.80 g/mol
    Synonyms :NA
    Chemical Name :7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine-D4 hydrochloride
    Stock Status :Instock
    Sitagliptin D4 Hydrochloride

  • Product Mitapivat D8

    CAT. No :M1800001CAS. No :NA
    Mol. F :C24H18D8N4O3S
    Mol. Wt :458.60 g/molSynonyms :NA
    Chemical Name :N-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl-2,2,3,3,5,5,6,6-d8)phenyl)quinoline-8-sulfonamide
    Stock Status :Instock
    Mitapivat D8

  • Product (13C3,15N2)-Cefixime

    CAT. No :C320015CAS. No :79350-37-1(Unlabelled)
    Mol. F :C1313C3H15N315N2O7S2
    Mol. Wt :456.43 g/mol
    Synonyms :(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl-13C,15N2)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
    Chemical Name :(6R,7R)-7-((...
    (13C3,15N2)-Cefixime
show more products

Upcoming Events

All events

Pharmaceutical Industry Webinars